Longevity medicine has gone peptide-crazy
If there's a word that captures both the great promise and the persistent uncertainty of longevity medicine, it's peptides.
Jul 28, 2026
0
7
MeSH tree: D27.505
If there's a word that captures both the great promise and the persistent uncertainty of longevity medicine, it's peptides.
Jul 28, 2026
0
7
Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University ...
Jul 27, 2026
0
4
Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests ...
Jul 25, 2026
0
49
Cambridge scientists have solved the mystery of why both stimulating and blocking a particular "switch" in the brain can help people lose weight—findings that could help boost the effectiveness of obesity drugs.
Jul 24, 2026
0
432
Researchers at the Society of NeuroInterventional Surgery (SNIS) 23rd Annual Meeting presented an experimental neurointerventional technique designed to treat severe back pain, a leading cause of disability and opioid use, ...
Jul 23, 2026
0
5
A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors. But this strategy has been undermined by the tendency of T cells to tire out before finishing ...
Jul 23, 2026
0
107
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
29
Children exposed to opioids before birth may face increased risks of difficulties with vision, attention, behavior and learning during their school years, according to a new study.
Jul 22, 2026
0
2
Certain antibiotics are overused in most countries, while too few people receive the specific antibiotic treatments they need, according to a study of antibiotic use across 186 countries published in The Lancet Public Health ...
Jul 22, 2026
0
10
For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration of recombinant zoster vaccine (RZV) can affect early response and arthritis control, according ...
Jul 21, 2026
0
4